AHA: Daily Marijuana Use Linked to Incident Heart Failure
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 13, 2023 -- Daily marijuana use is associated with incident heart failure, and cannabis use disorder (CUD) is associated with increased odds of major adverse cardiac and cerebrovascular events (MACCE), according to two studies presented at the American Heart Association Scientific Sessions 2023, held from Nov. 11 to 13 in Philadelphia.
Yakubu Bene-Alhasan, M.D., M.P.H., from Medstar Health in Baltimore, and colleagues used data from the National Institutes of Health "All of Us" Research Program to examine the association between the frequency of marijuana use and new-onset heart failure. The researchers found there were 2,958 events within a median follow-up of 45 months from a final population of 156,999 patients. Daily marijuana use was associated with an increased risk for incident heart failure compared with never use (adjusted hazard ratio, 1.34; 95 percent confidence interval, 1.04 to 1.72). After the addition of coronary artery disease diagnosis as a time-varying covariate in the main model, the association was attenuated and no longer significant (adjusted hazard ratio, 1.27; 95 percent confidence interval, 0.99 to 1.62).
Avilash Mondal, M.D., from Nazareth Hospital in Philadelphia, and colleagues examined the association between CUD in elderly nonsmokers with established cardiovascular disease risk and MACCE. The researchers found that 13.9 percent of 28,535 elderly cannabis users reported MACCE episodes. Compared with the non-CUD cohort, the CUD cohort reported higher MACCE (odds ratio, 1.20), all-cause mortality, dysrhythmia, acute myocardial infarction, transfer to other facilities, and home health care. In CUD users, chronic lung disease, renal disease, hypertension, and hyperlipidemia were predictors of MACCE episodes.
"The main public message is to be more aware of the increased risks and open the lines of communication so that cannabis use is acknowledged and considered," Mondal said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Racial Disparity Seen in Naloxone Administration
FRIDAY, May 31, 2024 -- In Pennsylvania, from 2019 to 2021, Black people who died from overdose deaths had lower odds of naloxone administration compared with White and Hispanic...
Semaglutide Reduces Need for Diuretics in Heart Failure
THURSDAY, May 16, 2024 -- Semaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in patients with heart...
Male, Female V1421 Carriers Face Similar Risk for Heart Failure Hospitalization
THURSDAY, May 16, 2024 -- Male and female V1421 carriers face a similar and substantial risk for heart failure hospitalization, according to a study published online May 12 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.